A phenotypic characterization of two isolates of a multidrug-resistant outbreak strain of mycobacterium tuberculosis with opposite epidemiological fitness by Bei, Jinlong et al.
Research Article
A Phenotypic Characterization of Two Isolates of a Multidrug-
Resistant Outbreak Strain of Mycobacterium tuberculosis with
Opposite Epidemiological Fitness
Jinlong Bei ,1 María Mercedes Bigi,2 Analía Lima,3 Qi Zhang,1 Federico Carlos Blanco,4
Beatriz Lopez,5 Ting Yu,1 Zhilin Wang,1 Zhangyan Dai,1 Zhuang Chen,1
Angel Adrian Cataldi ,4 María del Carmen Sasiain ,6 Viviana Ritacco ,5
Silvia De la Barrera ,6 Marcelo Abel Soria ,2 Rosario Durán,3 and Fabiana Bigi 4
1AGRO-Biological Gene Research Center, Guangdong Academy of Agricultural Sciences (GDAAS), Guangzhou, China
2University of Buenos Aires (UBA), School of Agronomy, Facultad de Agronomía (Universidad de Buenos Aires,
Facultad de Agronomía), Buenos Aires, Argentina
3Institut Pasteur de Montevideo & Instituto de Investigaciones Biológicas Clemente Estable, Uruguay
4Institute of Biotechnology, National Institute of Agricultural Technology (INTA)/IABIMO-CONICET (Instituto de Biotecnología,
Instituto Nacional de Tecnología Agropecuaria), Argentina
5National Institute of Infectious Diseases ANLIS Carlos Malbrán (Instituto Nacional de Enfermedades Infecciosas-ANLIS
Carlos Malbrán), Buenos Aires, Argentina
6IMEX-CONICET, National Academy of Medicine (IMEX-CONICET, Academia Nacional de Medicina), Buenos Aires, Argentina
Correspondence should be addressed to Fabiana Bigi; bigi.fabiana@inta.gob.ar
Received 8 January 2020; Revised 28 February 2020; Accepted 4 March 2020; Published 8 April 2020
Academic Editor: Marcelo A. Soares
Copyright © 2020 Jinlong Bei et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Tuberculosis (TB) is an infectious disease, caused byMycobacterium tuberculosis, primarily affecting the lungs. TheM. tuberculosis
strain of the Haarlem family named M was responsible for a large multidrug-resistant TB (MDR-TB) outbreak in Buenos Aires.
This outbreak started in the early 1990s and in the mid 2000s still accounted for 29% of all MDR-TB cases in Argentina. By
contrast, a clonal variant of strain M, named 410, has caused a single tuberculosis case since the onset of the outbreak. The
molecular bases of the high epidemiological fitness of the M strain remain unclear. To assess its unique molecular properties,
herein, we performed a comparative protein and lipid analysis of a representative clone of the M strain (Mp) and the
nonprosperous M variant 410. We also evaluated their growth in low pH. The variant 410 had higher levels of latency proteins
under standard conditions and delayed growth at low pH, suggesting that it is more sensitive to stress stimuli than Mp.
Moreover, Mp showed higher levels of mycolic acids covalently attached to the cell wall and lower accumulation of free mycolic
acids in the outer layer than the 410 strain. The low expression of latency proteins together with the reduced content of surface
mycolic acids may facilitate Mp to evade the host immune responses.
1. Introduction
Mycobacterium tuberculosis, the causative agent of tubercu-
losis (TB), achieves infection by deploying strategies that
involve bacterial uptake and replication in host macrophages
and by weakening or modulating host immune responses. TB
is still one of the leading causes of mortality worldwide.
Factors contributing to this situation are the HIV/AIDS pan-
demic, the deterioration of public health systems in develop-
ing countries and the emergence of multidrug-resistant
(MDR) and extremely drug-resistant (XDR) forms of TB.
In 2019, the World Health Organization (WHO) reported
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that 3.4% of new TB cases and 18% of previously treated
cases had MDR-TB or rifampicin-resistant TB (RR-TB)
(https://apps.who.int/iris/bitstream/handle/10665/329368/
9789241565714-eng.pdf?ua=1).
The M. tuberculosis strain named M, which belongs to
the Haarlem family, was responsible for a large and pro-
longed MDR-TB outbreak in Buenos Aires that started in
the early 1990s in a referral hospital for infectious diseases
[1]. Thereafter, the M strain has disseminated into the com-
munity, and between 2003 and 2009, it was still responsible
for 29% of all MDR-TB cases in Argentina [2]. This strain
has only recently started to decline [3]. By contrast, its clonal
variant 410 has caused a single tuberculosis case since the
onset of the outbreak [4].
Increasing evidence has shown that the M strain can
manipulate host immune responses for its own benefit. M
induces nonfunctional CD8+ cytotoxic T cell activity,
whereas its variant 410 induces a cytotoxic response compa-
rable to that of the strain H37Rv [5, 6]. The cytotoxic T cell
activity is associated with lysis of M. tuberculosis-infected
macrophages [7] and, as a consequence, reducedM. tubercu-
losis viability [8]. The poor cytotoxic activity induced in M
infection may allow the bacteria to evade the immune system
and persist in the hosts.
In monocyte-derived macrophages, M grows more
slowly and induces lower levels of TNF-α and IL-10 than
410. By contrast, in the human promonocytic U937 cell line,
bothM and 410 display similar growth patterns [4]. StrainM,
however, induces a significantly higher proinflammatory
response than 410. Thus, its interaction with the host cells
is not sufficient to explain the high epidemiological success
of the strain M.
Recently, we searched for all polymorphisms occurring
between an early representative of the M prototype strain,
hereafter named Mp, and its contemporary variant 410. In
that study, polymorphisms located in 11 proteins and five
intergenic regions were identified [9]. Some of these polymor-
phisms were located in proteins or promoter regions involved
in the metabolism of cell wall components, whereas others
occurred in proteins associated with drug resistance [9].
Some progress has been made in the understanding of the
molecular mechanisms that determine the epidemiological
success of certain M. tuberculosis lineages and of the M fam-
ily in particular. The molecular bases of the high epidemio-
logical fitness of strain Mp, however, remain unclear.
The objective of this study was to shed light on the molec-
ular bases that sustain the epidemiological success of Mp. For
this purpose, we followed a proteomic approach by compar-
ing the complete cellular proteome of both strains and per-
formed a lipid analysis by thin layer chromatography.
This work shows evidence that relates the transmission
capacity of a MDR Haarlem strain of M. tuberculosis with
the accumulation of stress proteins and the distribution of
mycolic acids in the subcomponents of the cell wall.
2. Methods
2.1. M. tuberculosis Isolates. TheM. tuberculosis Mp and 410
strains belong to the Haarlem H2 genotype (SIT 2, SNP-
barcode sublineage 4.1.2.1). The strains are resistant to
pyrazinamide, streptomycin, isoniazid, and rifampicin.
Mp is also resistant to kanamycin and ethambutol. Both
strains are genetically close, since they have similar molec-
ular markers [9].
2.2. Protein Extraction, Digestion, and TMT Labelling. The
M. tuberculosis strains were grown for 45 days without agita-
tion in Middlebrook 7H9 supplemented with 0.4% glycerol,
0.5% bovine albumin, and 0.4% glucose without Tween 80
in sealed T75 flasks at 37°C. The bacterial cells were centri-
fuged at 1,000× g for 20min at 4°C. The pellets were washed
with buffer phosphate saline, resuspended in ice-cold lysis
buffer (50mM Tris-HCl, pH7.5, 25mM NaCl, 5mM DTT,
and 1mM PMSF), and transferred to a 2ml screw cap micro-
centrifuge tube containing 0.1mm glass beads (Sigma-
Aldrich). The cells were disrupted with a Precellys 24 homog-
enizer (Bertin Instruments) by three cycles of the bead beater
for 20 s at 6m s−1. The homogenates were centrifuged at
10,000× g for 10min before adding ice-cold lysis buffer 2
(7M urea, 2M thiocarbamide, 1% CHAPS, and protease
inhibitor) to the resulting pellets. The supernatants were then
precipitated with three volumes of ice-cold acetone and incu-
bated at -20°C for 4 h. The protein pellets were resuspended
in a buffer (200mM tetraethylammonium bromide, pH8.5,
8M urea, and 2M thiocarbamide). Protein concentrations
were determined by the Bradford assay using bovine serum
albumin as a standard. Triplicates of each strain were used
for the proteomic analysis.
A total of 100μg proteins was reduced with 200mM
Tris(2-carboxyethyl)phosphine (TCEP) at 37°C for 4 h and
alkylated for 30min in the dark with 375mM iodoacetamide.
Then, six volumes of prechilled acetone were added and
incubated overnight at -20°C. The protein pellets were resus-
pended in 100mM tetraethylammonium bromide. Subse-
quently, the samples were digested using trypsin (Promega)
at a ratio of 1 : 50 overnight at 37°C. The digested peptides
were labelled with 6-plex TMT reagents according to the
manufacturer’s instructions (Thermo Scientific). The TMT
labelling efficiency was assessed by Orbitrap Fusion, and then
the samples were combined and fractionated by high pH
reversed-phase (hpRP) fractionation as described below.
2.3. High pH Reversed-Phase Fractionation. The mixed TMT
labelled peptides were desalted with Sep-Pak SPE cartridges
(Waters) for subsequent hpRP separation in a Dionex Ulti-
Mate 3000 model as described previously [10]. Finally, 48
collected fractions were merged into 12 mixtures (Supple-
mentary figure 1).
2.4. Nano-LC-MS/MS Analysis by Orbitrap Fusion. The
nano-LC-MS/MS analysis was carried out on an Orbitrap
Fusion Tribrid (Thermo Fisher Scientific, San Jose, CA) mass
spectrometer connected to an UltiMate 3000 RSLCnano Sys-
tem (Dionex, Thermo Fisher, Sunnyvale, CA). All mixtures
were reconstituted in 2% acetonitrile and 0.1% formic acid.
Each reconstituted mixture was loaded on a PepMap C18
trapping column (3μm, 75μm× 2 cm, Dionex) at 6μl/min,
and peptides were separated on a PepMap C18 RP analytical
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column (2μm, 50 μm× 15 cm, Dionex) at 300 nl/min. A
163min gradient was used as follows: 2-6% buffer B (100%
ACN and 0.1% formic acid) for 5min; 6-22% buffer B,
100min; 22-35% buffer B, 30min; 35-90% buffer B, 5min;
90% buffer B, 10min; 90-2% buffer B, 2min; and 2% buffer
B, 11min, before returning to buffer A (2% ACN and 0.1%
formic acid).
The separated peptides were analysed on the Orbitrap
Fusion with a nanospray voltage of 1.9 kV and a source
temperature of 275°C in the positive ion mode. Full MS
spectra were acquired on the Orbitrap at a resolution of
120,000, across a mass range of 350 to 1,550m/z. The
automatic gain control target of MS1 was set to 2 × 105
with a max injection time of 50ms. Tandem mass spectra
(with an automatic gain control target of 1 × 105 and a
maximum injection time of 80ms) were recorded on the
Orbitrap at a resolution of 30,000 and made by HCD at
a normalized collision energy of 40. The top 10 most
intense peaks were selected for fragmentation in each cycle
of the data-dependent mode. All data were acquired with
Xcalibur 3.1 software (Thermo Fisher Scientific).
2.5. Protein Identification and Quantitation. Data analysis
was carried out using PatternLab for Proteomics software
(version 4.1.1.15) [11]. A target-decoy database from M.
tuberculosis H37Rv sequences downloaded from UniProt
(March 2019) (https://www.uniprot.org), with the inclusion
of the 127 most common mass spectrometry contaminants,
was generated for the analysis. The raw files were searched
against the M. tuberculosis database using the Comet search
engine [12] and applying the following search parameters:
trypsin as a proteolytic enzyme with full specificity, methio-
nine oxidation and asparagine/glutamine deamidation as
the variable modification, and cysteine carbamidomethyla-
tion and lysine 6-plex TMT modification (including N-ter-
minus) as the fixed modification. The precursor ion
tolerance was set at 40 ppm, and a clear m/z range was spec-
ified from 127 to 131.
The peptide spectrum matches were filtered using Pat-
ternLab’s Search Engine Processor (SEPro), including MS2
in the results. An acceptable false discovery rate (FDR) cri-
terion was set at 1% of the protein level [13]. Results were
processed to filter out peptides with more than six amino
acid residues and proteins with a minimum of two spec-
trum matches.
The PatternLab for Proteomics isobaric analyser module
was used to analyse the data quantitatively. YADA software
[14] was employed with its default configuration on the
MS1 and MS2 extracted files. A peptide quantitation report
was generated using SEPro and YADA files and by setting
TMT-6 as the label according to instructions described previ-
ously [11].
2.6. Overrepresentation Test. A statistical overrepresentation
test of GO biological processes (release 20190606) was per-
formed using the Panther Server (http://pantherdb.org).
The release date of the GO dataset was 2019-02-02. The anal-
ysis was performed with the TubercuList gene identifiers
using theM. tuberculosis database as a reference list. Fisher’s
exact test type in combination with the calculated discovery
rate correction was used for the analysis [15].
2.7. Gene Expression. The RNA extractions were performed
as follows: Cultures of Mp and 410 were grown without agi-
tation inMiddlebrook 7H9 supplemented with 0.4% glycerol,
0.5% bovine albumin, 0.4% glucose, and 0.05% Tween 80 for
45-60 days at 37°C. The cultures were centrifuged, and cell
pellets were immediately resuspended in 1ml of TRIzol
(Sigma-Aldrich) and transferred to a 2ml screw cap micro-
centrifuge tube containing 0.1mm silica glass beads (Sigma-
Aldrich). The cells were disrupted with a Precellys 24 homog-
enizer (Bertin Instruments) by three cycles of the bead beater
for 20 s at 6m s−1, and total RNA was purified as previously
described [16]. The integrity of total RNA was assessed in a
0.8% agarose gel (Supplementary figure 2). Finally, the
RNA samples were treated with Ambion DNase I (Life
Technologies) following the manufacturer’s specifications.
RT-qPCR were performed as previously described [17]
with specific primers (Supplementary table 3). All qPCR
were performed in duplicate, and the average values of
duplicates were analysed using the LinRegPCR software
[18] as previously described [16]. The statistical analyses
were done with the fg statistic software [19].
2.8. Lipid Analysis. Total lipids from bacterial cells grown
until the stationary phase (OD600nm 0.8-1) in Middlebrook
7H9 supplemented with 0.5% glycerol, 0.5% bovine albumin,
and 0.4% glucose without agitation were extracted following
procedures described earlier [20]. Fatty acid and mycolic acid
methyl esters (FAMEs and MAMEs, respectively) were
derived from extractable lipids and delipided cells (cells
depleted from extractable lipids) as described by Stadthagen
et al. [20] and analysed by thin layer chromatography
(TLC) on silica gel 60F254 by loading 0.25mgr of lipids per
lane. TLCs were developed using η-hexane : ethyl acetate
(95 : 5 v/v) (thrice) and revealed by spraying with a CuSO4-
phosphoric acid solution and heating.
3. Results
3.1. In Vitro Growth of Mp and 410 Strains.We first assessed
the in vitro growth of the Mp and 410 strains by measuring
the optical density (OD) at 600nm of cultures incubated
without agitation in the presence of the detergent Tween
80. At 45-50 days of culturing, both strains entered the sta-
tionary phase (Figure 1), indicating that in this in vitro con-
dition of growth, Mp and 410 had similar fitness. The
oxygen availability assays revealed low content of oxygen in
the bacterial cultures at day 60, as evidenced by the complete
disappearance of blue coloration at this point (methylene
blue) (data not shown). These results indicate that at day
60, cultures of the Mp and 410 strains are in hypoxia.
3.2. Proteomic Analysis. We used a TMT-6plex labelling
strategy associated with two-dimensional liquid chromatog-
raphy and mass spectrometry in tandem to compare the total
cellular proteomes of the strains Mp and 410. We obtained
total cellular proteins from static cell cultures in the early sta-
tionary phase growth in sealed flasks. Detergents were
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omitted from the cultures to preserve the cell surface protein
content. For the proteomic analysis, we analysed three bio-
logical replicates per strain; each replicate consisted of a
mix of two batch cultures. Therefore, we analysed six inde-
pendent batch cultures for each strain.
The identified proteins covered ∼69% of the predicted
M. tuberculosis proteome (Supplementary table 1). The
proteomic analysis indicated a high level of similarity
between 410 and Mp when grown in vitro until the
stationary phase (Supplementary table 1), since only 12 of
the differentially accumulated proteins showed a fold change
(FC) greater than |2| and a P value below 0.01 between the
strains (Table 1). One of the most accumulated proteins in
the strain 410 was IdsA. This result is in accordance with the
results of our previous study, in which this protein, a
geranylgeranyl pyrophosphate synthetase protein likely
involved in lipid biosynthesis, showed higher levels of
transcription in 410 than in Mp [9]. The strain 410 also
accumulated three proteins from the DevR regulon (Rv0569,
Rv2031c, and Rv2007c), two proteins of unknown functions
(Rv3221c and Rv2081c), a GCN5-related N-acetyltransferase
(Eis, Rv2416c), and a putative ribonuclease E (Rv2444c).
Rv2057c, Rv2058c, Rv2154c, and Rv0290 showed a
higher accumulation in Mp. Rv2057c and Rv2058c are ribo-
somal proteins, whereas Rv2154c is the peptidoglycan glyco-
syltransferase FtsW, which seems to participate in the
peptidoglycan synthesis [21]. On the other hand, Rv0290 is
an ESX-3 secretion system protein.
A global enrichment analysis considering all differentially
accumulated proteins (FC > ∣1:3∣ and pVal < 0:03) showed
the protein families that distinguished both strains. Whereas
Mp accumulated proteins associated with active metabolism,
410 had more protein families related to stress and hypoxia
(Table 2 and Supplementary table 2).
3.3. Transcriptional Analysis of the DevR Regulon.DevR is the
response regulator of a two-component system, which is acti-
vated in response to hypoxia and upon exposure to a number
of stresses [22].
Because the proteomic results showed higher abundance
of stress proteins in the 410 strain, we next measured the
transcriptional level of the DevR-regulated proteins Rv0569,
Rv2007c, and hspX at the early and late exponential phases.
We also assessed the transcription level of Rv1738c, because
this gene encodes a key component of a stress response sys-
tem [23] and because its FC was close to the cut-off estab-
lished in the proteomic analysis (FC 1.990).
In the early stationary (OD600nm~0.8) growth phase, the
strain 410 showed a significant upregulation of the transcrip-
tion of all genes except Rv0569 (Supplementary figure 3A) in
comparison to Mp. In the late stationary (OD600nm~1)
growth phase, on the other hand, Rv2007c, hspX, and Rv0569
were upregulated in the strain Mp; Rv1738 showed no
differences between strains (Supplementary figure 3B).
3.4. Response to Acid Stress. The dormancy or latency pro-
gram, in which the DevR regulon plays a central role, is a
survival mechanism that allows mycobacteria to resist unfa-
vourable conditions without replication. This program is
activated in response to a variety of stresses, such as starva-
tion, hypoxia, and low pH. To determine if the latent pheno-
type of the 410 strain is a consequence of a greater sensitivity
to stress conditions in comparison to the Mp strain, we eval-
uated the growth of Mp and 410 at pH5.7. The replication of
410 was delayed compared to that of Mp (Figure 2), suggest-
ing that 410 rapidly enters into a nonreplicative state under
unfavourable conditions.
3.5. Lipid Analysis. The proteomic analysis showed significant
variation between the Mp and 410 strains in the content of
enzymes involved in mycolic acid biosynthesis (Table 2).
Mycolic acids are very long-chain α-alkyl β-hydroxy fatty
acids present in the cell wall of the Mycolata taxon. In M.
tuberculosis, mycolic acids are similar in length but may har-
bour a variety of functional groups (such as double binds,
cyclopropanations (cis or trans), keto, and methoxy groups)
that give rise to a number of subfamilies [24]. They can be
covalently attached to the cell wall arabinogalactan or can be
esterified to trehalose to produce trehalose monomycolate
(TMM) and trehalose dimycolate (TDM) [25], or they can
remain free. Given the importance of mycolic acids in the
interaction of M. tuberculosis with the host [26], we subse-
quently assessed the mycolic acid content in both strains.
A TLC analysis of fatty acid methyl esters (FAMEs) and
mycolic acid methyl esters (MAMEs) from the extractable
cellular lipids showed an increase in the mycolic acid content
of the strain 410 in comparison to the strain Mp (Figure 3(a)
and Supplementary figure 4A). By contrast, the content of
mycolic acids attached to the cell wall was higher in Mp
than in 410 (Figure 3(b) and Supplementary figure 4B).
These phenotypes were reproducible throughout more than
three independent experiments.
Altogether, these results demonstrated that although the
total abundance of mycolic acids is equivalent in both strains,
their distribution in the outer and inner leaflets of the myco-
membrane varies.
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Figure 1: In vitro growth of Mp and 410 strains. The evaluated M.
tuberculosis strains were grown in Middlebrook 7H9 supplemented
with 0.5% glycerol, 0.5% bovine albumin, 0.4% glucose, and 0.05%
Tween 80. The bacterial growth was determined by OD600nm.
Data represent the mean ± SD of three independent replicates.
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4. Discussion
In this study, we investigated the molecular mechanisms
responsible for the differential transmissibility of the epi-
demic strain Mp and its sporadic variant 410. To this pur-
pose, we determined the relative abundance of total cellular
proteins of both strains grown until reaching the stationary
phase without aeration by following a robust proteomic
approach. The approach consisted of the simultaneous detec-
tion, in the same run, of the peptides expressed in all the sam-
ples and replicates, thus avoiding the experimental variability
inherent to multiple runs.
This analysis retrieved nearly 62% of the M. tuberculosis
proteome. In a previous study, Albrethsen et al. [27] have
identified 1,176 proteins in a culture supernatant ofM. tuber-
culosis. Considering that the secreted proteins were excluded
in our study and that these subsets of proteins represent a
high proportion of total proteins [27], we can conclude that
the coverage in our proteomic analysis is appropriate.
In our study, the high level of genomic conservation
between the strains Mp and 410 [9] was translated to similar
proteomes for the Mp and 410 strains. Only 12 proteins
showed higher accumulation (FC > 2) in one strain relative
to the other. Most of the detected proteins differed by no
more than 1.5-folds between the strains.
DevR is the response regulator of a two-component sys-
tem, which is activated in response to hypoxia and nitric
oxide by the histidine kinases DevS or DosT [22]. Boon and
Dick [28] have reported that DevR is responsible for the dor-
mancy/latent stage of M. tuberculosis and that upon muta-
tion of devR, the bacteria fails to enter dormancy and thus
dies in a Wayne culture system of hypoxia. Furthermore,
the exposure of M. tuberculosis mutants lacking DevR to
low oxygen tension induces the expression of more than
100 genes, of which 48 are under the control of DevR [22].
In this study, at the early stationary phase in the presence
of detergent, the 410 strain showed higher transcription of
key stress DevR genes (Rv1738, Rv2007c, and hspX) than
the Mp strain under that condition, which is concordant with
our proteomic results. By contrast, at the late stationary
phase, the strain 410 downregulated transcription of the
stress genes Rv0569, Rv2007c, and hspX. These results indi-
cate that the timing of stress response varies between strains.
Moreover, the delayed replication of the 410 strain at low pH
supports the idea that this strain activates the DevR program
more rapidly than the Mp strain under stress stimuli.
Altogether, these results suggest that Mp displays lower
sensitivity to stress stimuli and remains metabolically active
longer than the 410 strain. In accordance with this conclu-
sion, Mp accumulated higher amounts of proteins involved
in translation (Rv2058c and Rv2057c) and cell division
(FstW), whereas 410 overexpressed Rv1738, a protein likely
involved in the shutdown of the ribosomal protein synthesis
of M. tuberculosis induced under nitrosative and hypoxia
stresses [23].
In a previous study, we identified two proteins with S-
adenosylmethionine- (SAM-) dependent methyltransferase
domains, Rv3787c and CmaA2, as polymorphic between
the 410 and Mp strains [9]. According to TBDB (http://
genome.tbdb.org/), Rv0081 has a putative binding site in
the promoter region of Rv3787c, which suggests that
Rv3787c is part of the Rv0081 regulon. Interestingly, herein,
the strain Mp accumulated less hypoxia-related proteins than
the strain 410 under an oxygen-limited condition. Thus, the
fact that Rv0081 is a hub regulator involved in the adaptation
ofM. tuberculosis to hypoxic condition [29] may connect the
polymorphism of Rv3787c to a retarded response of Mp to
hypoxia. Nevertheless, this hypothesis needs to be demon-
strated with experimental evidence.
Mariotti et al. [30] have demonstrated that latent M.
tuberculosis displays higher capacity to stimulate specific
human T lymphocytes than replicative M. tuberculosis. In
addition, Mp induced a poor activation of cytotoxic CD8+
T cells from healthy donors in ex vivo experiments, in com-
parison to 410 and H37Rv [5, 31]. Thus, the latent phenotype
of 410 may impair its capacity of evading the immune system
in relation toMp. However, the role of latency in tuberculosis
transmission is not completely clear. For instance, the DevR
Table 1: Most differentially accumulated proteins between Mp and 410 strains.
Protein Rv number Log 2 fold changea P value Description
Rv3221c Rv3221c -2.78 8.20E-03 Biotinylated protein
IdsA2 Rv2173 -2.57 1.20E-03 Probable geranylgeranyl pyrophosphate synthetase
Rv0569 Rv0569 -2.55 1.90E-03 Uncharacterized protein
hspX Rv2031c -2.52 1.20E-09 alpha-Crystallin
fdxA Rv2007c -2.27 3.40E-04 Ferredoxin
Eis Rv2416c -2.19 6.70E-03 N-acetyltransferase Eis
Rv2081c Rv2081c -2.16 1.20E-02 Uncharacterized protein
Rne Rv2444c -2.06 3.90E-03 Possible ribonuclease E
RpmB2 Rv2058c 2.03 2.40E-03 50S ribosomal protein
FtsW Rv2154c 2.07 1.00E-02 Probable peptidoglycan glycosyltransferase
EccDE Rv0290 2.22 5.90E-03 ESX-3 secretion system protein
RpmG1 Rv2057c 2.77 5.10E-03 50S ribosomal protein
aLog 2 fold change in the protein relative abundance of the strain M with respect to the strain 410. Negative fold-change values indicate that proteins are
overrepresented in the strain 410.
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latent regulon of members of theW-Beijing family, which is a
lineage with an epidemic spread, is constitutively upregulated
[32]. Reed et al. proposed this phenomenon as an advantage
toM. tuberculosis that allows perpetuation and rapid dissem-
ination of the population. Conversely, Duncan et al. [33]
showed that an M. tuberculosis natural mutant circulating
among homeless people in Canada displayed decreased
expression of the hypoxia-induced regulon DevR in relation
to its isogenic wild-type strain. Therefore, this last study sug-
gests that the lack of latency proteins does not affect the
transmission of M. tuberculosis.
The TLC analysis showed increased mycolic acid trans-
ferred into the cell wall and the simultaneous lower abun-
dance of free mycolic acids in the Mp strain in relation to
the 410 strain. The reasons of this differential distribution
of mycolic acids in Mp and 410 are still unclear. However,
previous findings and the findings presented in the current
study may explain in part this result. For instance, Telenti
et al. have previously reported that a treatment of mycobac-
teria with ethambutol produced the opposed imbalance in
mycolic acid distribution, with increased accumulation of
free mycolates and reduced transfer of these lipids to the cell
wall [34]. Ethambutol inhibits EmbB (Rv3795), which is an
arabinosyltransferase involved in the synthesis of the myco-
bacterial cell wall arabinan [35]. Interestingly, Mp carries a
mutation in embB [9] that may be associated with resistance
Table 2: Global enrichment analysis of differentially accumulated proteins between the Mp and 410 strains.
(a)
Mp
Mycobacterium
tuberculosis (REF)
Text box input
GO biological process
complete
# # Expected Fold enrichment +/− Raw P value FDR Genes
tRNA aminoacylation
for protein translation
20 14 2.26 6.18 + 2.13E-06 1.32E-04
pheT, asps, alas, SerS, tyrS, lysS1, proS,
gltX, leuS, argS, hiss, metG, cysS, valS
Mycolic acid
biosynthetic process
12 7 1.36 5.15 + 1.82E-03 4.51E-02
mmaA2, kasB, inhA, mmaA4,
cmaA2, cmaA1, mmaA3
Glutamine metabolic
process
20 10 2.26 4.42 + 4.92E-04 1.60E-02
glnA2, asnB, glnA4, gltB, cobQ, hisH,
glmS, pyrG, pknG, guaA
Tricarboxylic
acid cycle
25 11 2.83 3.89 + 6.03E-04 1.85E-05
icd2, gabD1, glcB, citA, gabD2, can,
lpdC, sdhA, icd, sdhB, fumC
Ribonucleoside
monophosphate
biosynthetic process
32 12 3.62 3.31 + 1.07E-03 3.02E-02
purT, purH, pyrD, purD, purA,
purB, add, purr, carB, guaA, purM, prs
Ribonucleoside
metabolic process
88 22 9.96 2.21 + 1.92E-03 4.54E-02
relA, tesB2, purT, pyk, pfkA, purH,
pyrD, gpmA, glcB, Rv0386, aceE,
purD, coax, lpdC, purA, pyrG, fba,
purB, purU, carB, guaA, purM
Nucleotide biosynthetic
process
93 23 10.53 2.18 + 1.50E-03 4.05E-02
ppnK, nrdF2, cmk, relA, purT, dcd,
nadD, purH, pyrD, nadE, Rv0386, nrdF1,
Rv2488c, purD, coax, purA, pyrG, purB,
purU, carB, guaA, purM, prs
(b)
410
Mycobacterium
tuberculosis (REF)
Text box input
GO biological process
complete
# # Expected Fold enrichment +/− Raw P value FDR Genes
Protein folding 14 5 0.33 15.17 + 5.21E-05 1.62E-02 groEL2, dnaK, grosS, grpE, hspX
Response to hypoxia 46 15 1.08 13.85 + 2.54E-12 5.54E-09
groEL2, fdxA, devR, Rv2623, hmp,
icl, Rv0569, Rv2005c, narX, acg,
Rv2629, hspX, Rv3134c, hrp1
Positive regulation of
cellular process
33 6 0.78 7.72 + 2.23E-04 4.86E-02 dnaK, devR, phoP, lpqH, bpa, hbhA
Response to host
immune response
129 11 3.04 3.62 + 3.10E-04 6.14E-02
fdxA, Eis, desA1, icl, lprA, acg,
hspX, lpqH, sodC, Rv1738, hrp1
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to ethambutol. Thus, this mutation in Mp may improve
the enzymatic activity of EmbB, increasing the availability
of arabinogalactan for mycolylation.
M. tuberculosis has five S-adenosylmethionine- (SAM-)
dependent methyltransferases that participate in the cyclopro-
panation of mycolic acids (MmaA2, MmaA1, CmaA1,
CmaA2, and PcaA). Thus, polymorphisms in the methyltrans-
ferases Rv3787c and CamA2 may also contribute to the differ-
ential profile of mycolic acids in the 410 and Mp strains.
In addition, Dulberger et al. have proposed a model for
mycobacterial cell wall remodelling in growth and stasis
[26], in which free mycolic acids increase during stasis, while
TDM, TMM, and mycolated arabinogalactan decrease or
keep constant. According to this model, the 410 strain dis-
played a more “stasis” lipid profile relative to the Mp strain.
In fact, these profiles are consistent with the proteomic
results of this study. However, we did not detect a significant
decrease in TDM and TMM content in the 410 strain in rela-
tion to the Mp strain in the TLC experiments (Supplemen-
tary figure 4C).
Substantial evidence demonstrates that modified mycolic
acids play specific and diverse roles inM. tuberculosis patho-
genesis [36, 37, 38]. Indeed, the complete lack of mycolate
cyclopropanation suppresses the host immune response
[39]. These previous observations suggest that the decrease
in free mycolic acids in the strain Mp can also contribute to
the lower immune response induced ex vivo by this strain
in human cells [40].
Although the most distinctive feature of the strain Mp
with respect to the variant 410 is its ability to perpetuate in
the community, both strains are highly conserved at the
genomic [9] and proteomic (this study) levels. Thus, the
few differences detected in stress protein accumulation and
mycolic acid localization between strains may play a central
role in the epidemiological behaviour ofM. tuberculosis. This
hypothesis needs to be confronted with further experimental
evidence from the study of otherM. tuberculosis strains with
different transmissibility.
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Figure 2: In vitro growth of Mp and 410 strains at low pH. The
assessed M. tuberculosis strains were grown in Middlebrook 7H9
supplemented with 0.5% glycerol, 0.5% bovine albumin, 0.4%
glucose, and 0.05% Tween 80 at pH5.7. The bacterial growth was
determined by OD600nm measurements. One experiment of three
with similar results is shown in the figure.
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Figure 3: The strains 410 and Mp showed different content of
mycolates. Fatty acid and mycolic acid methyl esters (FAMEs and
MAMEs, respectively) were derived from extractable lipids (a) and
delipided cells (b) of Mp and 410 strains cultured in 7H9
supplemented with 0.5% glycerol, 0.5% bovine albumin, and 0.4%
glucose without agitation until reaching the stationary growth
phase. TLC plates were developed in the solvent system η-
hexane : ethyl acetate (95 : 5) (thrice) and revealed with CuSO4 and
heating.
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Supplementary Materials
Supplementary Material: Supplementary Table 1, Supple-
mentary Table 2, and Supplementary Table 3. Supplementary
Figure 1: (a) chromatogram profile of the high pH reversed-
phase (hpRP) fractionation. (b) Schematic representation of
the 48 fractions collected in the hpRP chromatography. The
labels M1 toM12 in each well indicate the pattern of mixture.
Supplementary Figure 2: total RNA obtained from cultures in
the stationary phase (OD600nm~ 1) and resolved in 0.8%
agarose gel. Supplementary Figure 3: comparative gene
expression of selected DevR regulon genes between strains
by RT-qPCR at (a) early stationary and (b) late stationary
growth phases. Fold changes of Mp/410 strains were calcu-
lated using the expression levels of the sigA mRNA as a ref-
erence gene and the 410 variant as a calibrator. Data were
analysed using a random permutation test (fg statistic soft-
ware ∗P < 0:05). The bars represent average expression ratios
of six samples ± SD between the Mp strain and the 410 vari-
ant. Supplementary Figure 4: FAMEs and MAMEs were
derived from extractable lipids (a) and delipided cells (b) of
the Mp and 410 strains. TLC plates were developed in the sol-
vent system η-hexane : ethyl acetate (95 : 5) (thrice) and
revealed with CuSO4 and heating. (c) Total extractable lipids
of the Mp and 410 strains were analysed by TLC developed in
the solvent system chloroform :methanol : water (90 : 10 : 1).
(Supplementary Materials)
References
[1] V. Ritacco, M. Di Lonardo, A. Reniero et al., “Nosocomial
spread of human immunodeficiency virus-related multidrug-
resistant tuberculosis in Buenos Aires,” The Journal of Infec-
tious Diseases, vol. 176, no. 3, pp. 637–642, 1997.
[2] V. Ritacco, M. J. Iglesias, L. Ferrazoli et al., “Conspicuous
multidrug-resistantMycobacterium tuberculosis cluster strains
do not trespass country borders in Latin America and Spain,”
Infection, Genetics and Evolution, vol. 12, no. 4, pp. 711–717,
2012.
[3] J. Monteserin, L. Pérez-Lago, N. Yokobori et al., “Trends of
two epidemic multidrug-resistant strains of mycobacterium
tuberculosis in Argentina disclosed by tailored molecular strat-
egy,” The American Journal of Tropical Medicine and Hygiene,
vol. 101, no. 6, pp. 1308–1311, 2019.
[4] N. Yokobori, B. López, L. Geffner et al., “Two genetically-
related multidrug-resistantMycobacterium tuberculosis strains
induce divergent outcomes of infection in two human macro-
phage models,” Infection, Genetics and Evolution, vol. 16,
pp. 151–156, 2013.
[5] L. Geffner, N. Yokobori, J. Basile et al., “Patients with
multidrug-resistant tuberculosis display impaired Th1
responses and enhanced regulatory T-cell levels in response
to an outbreak of multidrug-resistantMycobacterium tubercu-
losisMand Ra strains,” Infection and Immunity, vol. 77, no. 11,
pp. 5025–5034, 2009.
[6] J. I. Basile, L. J. Geffner, M. M. Romero et al., “Out-
breaks of Mycobacterium tuberculosis MDR strains induce
high IL-17 T-cell response in patients with MDR tuber-
culosis that is closely associated with high antigen load,” The
Journal of Infectious Diseases, vol. 204, no. 7, pp. 1054–1064,
2011.
[7] N. Yokobori, C. A. Sabio y García, L. Geffner et al., “Differ-
ential induction of macrophage cell death by antigens of a
clustered and a non-clustered multidrug-resistant Mycobac-
terium tuberculosis strain from Haarlem family,” FEMS
Immunology and Medical Microbiology, vol. 66, no. 3,
pp. 363–371, 2012.
[8] S. Cho, V. Mehra, S. Thoma-Uszynski et al., “Antimicrobial
activity of MHC class I-restricted CD8+ T cells in human
tuberculosis,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 97, no. 22, pp. 12210–
12215, 2000.
[9] M. M. Bigi, B. Lopez, F. C. Blanco et al., “Single nucleotide
polymorphisms may explain the contrasting phenotypes of
two variants of a multidrug-resistant Mycobacterium tubercu-
losis strain,” Tuberculosis, vol. 103, pp. 28–36, 2017.
[10] N. Amigo, Q. Zhang, A. Amadio et al., “Overexpressed pro-
teins in hypervirulent clade 8 and clade 6 strains of Escherichia
coli O157: H7 compared to E. coli O157:H7 EDL933 clade 3
strain,” PLoS One, vol. 11, no. 11, p. e0166883, 2016.
[11] P. C. Carvalho, D. B. Lima, F. V. Leprevost et al., “Integrated
analysis of shotgun proteomic data with PatternLab for prote-
omics 4.0,” Nature Protocols, vol. 11, no. 1, pp. 102–117, 2016.
[12] J. K. Eng, M. R. Hoopmann, T. A. Jahan, J. D. Egertson, W. S.
Noble, and M. J. MacCoss, “A deeper look into Comet - imple-
mentation and features,” Journal of the American Society for
Mass Spectrometry, vol. 26, no. 11, pp. 1865–1874, 2015.
[13] P. C. Carvalho, J. S. G. Fischer, T. Xu, J. R. Yates III, and V. C.
Barbosa, “PatternLab: from mass spectra to label-free differen-
tial shotgun proteomics,” Current Protocols in Bioinformatics,
vol. 40, no. 1, 2012.
[14] P. C. Carvalho, T. Xu, X. Han, D. Cociorva, V. C. Barbosa, and
J. R. Yates III, “YADA: a tool for taking the most out of high-
resolution spectra,” Bioinformatics, vol. 25, no. 20, pp. 2734–
2736, 2009.
[15] H. Mi, S. Poudel, A. Muruganujan, J. T. Casagrande, and P. D.
Thomas, “PANTHER version 10: expanded protein families
and functions, and analysis tools,” Nucleic Acids Research,
vol. 44, no. D1, pp. D336–D342, 2016.
[16] M. M. Bigi, F. C. Blanco, F. R. Araújo et al., “Polymorphisms of
20 regulatory proteins between Mycobacterium tuberculosis
and Mycobacterium bovis,” Microbiology and Immunology,
vol. 60, no. 8, pp. 552–560, 2016.
[17] M. Santangelo, L. Klepp, J. Nuñez-García et al., “Mce3R, a
TetR-type transcriptional repressor, controls the expression
of a regulon involved in lipid metabolism in Mycobacterium
tuberculosis,” Microbiology, vol. 155, no. 7, pp. 2245–2255,
2009.
[18] C. Ramakers, J. M. Ruijter, R. H. L. Deprez, and A. F. M.Moor-
man, “Assumption-free analysis of quantitative real-time poly-
merase chain reaction (PCR) data,” Neuroscience Letters,
vol. 339, no. 1, pp. 62–66, 2003.
[19] J. Di Rienzo, M. Balzarini, F. Casanoves et al., Infostat-Sofware
estadístico, Universidad Nacional de Córdoba, Argentina,
2013.
[20] G. Stadthagen, J. Korduláková, R. Griffin et al., “p-Hydroxy-
benzoic acid synthesis in Mycobacterium tuberculosis,” The
Journal of Biological Chemistry, vol. 280, no. 49, pp. 40699–
40706, 2005.
[21] P. Datta, A. Dasgupta, A. K. Singh, P. Mukherjee, M. Kundu,
and J. Basu, “Interaction between FtsW and penicillin-
binding protein 3 (PBP3) directs PBP3 to mid-cell, controls
8 BioMed Research International
cell septation and mediates the formation of a trimeric com-
plex involving FtsZ, FtsW and PBP3 in mycobacteria,” Molec-
ular Microbiology, vol. 62, no. 6, pp. 1655–1673, 2006.
[22] D. R. Sherman, M. Voskuil, D. Schnappinger, R. Liao, M. I.
Harrell, and G. K. Schoolnik, “Regulation of the Mycobacte-
rium tuberculosis hypoxic response gene encoding α-crystal-
lin,” Proceedings of the National Academy of Sciences, vol. 98,
no. 13, pp. 7534–7539, 2001.
[23] R. D. Bunker, K. Mandal, G. Bashiri et al., “A functional role of
Rv1738 in Mycobacterium tuberculosis persistence suggested
by racemic protein crystallography,” Proceedings of the
National Academy of Sciences, vol. 112, no. 14, pp. 4310–
4315, 2015.
[24] M. A. Forrellad, L. I. Klepp, A. Gioffré et al., “Virulence factors
of the Mycobacterium tuberculosis complex,” Virulence, vol. 4,
no. 1, pp. 3–66, 2014.
[25] J. T. Belisle, V. D. Vissa, T. Sievert, K. Takayama, P. J. Brennan,
and G. S. Besra, “Role of the major antigen of Mycobacterium
tuberculosis in cell wall biogenesis,” Science, vol. 276, no. 5317,
pp. 1420–1422, 1997.
[26] C. L. Dulberger, E. J. Rubin, and C. C. Boutte, “The mycobac-
terial cell envelope – a moving target,” Nature Reviews. Micro-
biology, vol. 18, no. 1, pp. 47–59, 2020.
[27] J. Albrethsen, J. Agner, S. R. Piersma et al., “Proteomic profil-
ing of Mycobacterium tuberculosis identifies nutrient-
starvation-responsive toxin-antitoxin systems,” Molecular &
Cellular Proteomics, vol. 12, no. 5, pp. 1180–1191, 2013.
[28] C. Boon and T. Dick, “Mycobacterium bovis BCG response
regulator essential for hypoxic dormancy,” Journal of Bacteri-
ology, vol. 184, no. 24, pp. 6760–6767, 2002.
[29] J. E. Galagan, K. Minch, M. Peterson et al., “The Mycobacte-
rium tuberculosis regulatory network and hypoxia,” Nature,
vol. 499, no. 7457, pp. 178–183, 2013.
[30] S. Mariotti, M. Pardini, M. C. Gagliardi et al., “DormantMyco-
bacterium tuberculosis fails to block phagosome maturation
and shows unexpected capacity to stimulate specific human
T lymphocytes,” Journal of Immunology, vol. 191, no. 1,
pp. 274–282, 2013.
[31] L. Geffner, J. I. Basile, N. Yokobori et al., “Mycobacterium
tuberculosis multidrug resistant strain M induces an altered
activation of cytotoxic CD8+ T cells,” PLoS One, vol. 9, no. 5,
p. e97837, 2014.
[32] M. B. Reed, S. Gagneux, K. DeRiemer, P. M. Small, and C. E.
Barry, “The W-Beijing lineage of Mycobacterium tuberculosis
overproduces triglycerides and has the DosR dormancy regu-
lon constitutively upregulated,” Journal of Bacteriology,
vol. 189, no. 7, pp. 2583–2589, 2007.
[33] C. Duncan, F. B. Jamieson, J. L. Troudt et al., “Whole tran-
scriptomic and proteomic analyses of an isogenic M. tubercu-
losis clinical strain with a naturally occurring 15 kb genomic
deletion,” PLoS One, vol. 12, no. 6, p. e0179996, 2017.
[34] A. Telenti, W. J. Philipp, S. Sreevatsan et al., “The emb operon,
a gene cluster ofMycobacterium tuberculosis involved in resis-
tance to ethambutol,” Nature Medicine, vol. 3, no. 5, pp. 567–
570, 1997.
[35] L. J. Alderwick, J. Harrison, G. S. Lloyd, and H. L. Birch, “The
mycobacterial cell wall—peptidoglycan and arabinogalactan,”
Cold Spring Harbor Perspectives in Medicine, vol. 5, no. 8, arti-
cle a021113, 2015.
[36] E. Dubnau, J. Chan, C. Raynaud et al., “Oxygenated mycolic
acids are necessary for virulence of Mycobacterium tuberculo-
sis in mice,” Molecular Microbiology, vol. 36, no. 3, pp. 630–
637, 2000.
[37] V. Rao, F. Gao, B. Chen, Jacobs WR Jr, and M. S. Glickman,
“Trans-cyclopropanation of mycolic acids on trehalose dimy-
colate suppressesMycobacterium tuberculosis-induced inflam-
mation and virulence,” The Journal of Clinical Investigation,
vol. 116, no. 6, pp. 1660–1667, 2006.
[38] V. Rao, N. Fujiwara, S. A. Porcelli, andM. S. Glickman, “Myco-
bacterium tuberculosis controls host innate immune activation
through cyclopropane modification of a glycolipid effector
molecule,” The Journal of Experimental Medicine, vol. 201,
no. 4, pp. 535–543, 2005.
[39] D. Barkan, D. Hedhli, H. G. Yan, K. Huygen, and M. S. Glick-
man, “Mycobacterium tuberculosis lacking all mycolic acid
cyclopropanation is viable but highly attenuated and hyperin-
flammatory in mice,” Infection and Immunity, vol. 80, no. 6,
pp. 1958–1968, 2012.
[40] L. Geffner, J. I. Basile, N. Yokobori et al., “CD4+ CD25(high)
Foxp3+ regulatory T lymphocytes suppress IFNγ and CD107
expression in CD4+ and CD8+ T cells from tuberculous pleural
effusions,” Clinical and Experimental Immunology, vol. 3,
pp. 1–11, 2013.
9BioMed Research International
